Caladrius SEC Filing | Lisata Therapeutics, Inc.

Filing date	Form	Description	View
Oct 27, 2011	4	Statement of changes in beneficial ownership of securities	View HTML 0001144204-11-059633.pdf 0001144204-11-059633.rtf 0001144204-11-059633.xls
Oct 27, 2011	4	Statement of changes in beneficial ownership of securities	View HTML 0001144204-11-059635.pdf 0001144204-11-059635.rtf 0001144204-11-059635.xls
Oct 17, 2011	8-K	Report of unscheduled material events or corporate event	View HTML 0001144204-11-057993.pdf 0001144204-11-057993.rtf 0001144204-11-057993.xls
Oct 4, 2011	4	Statement of changes in beneficial ownership of securities	View HTML 0001144204-11-056171.pdf 0001144204-11-056171.rtf 0001144204-11-056171.xls
Sep 30, 2011	8-K	Report of unscheduled material events or corporate event	View HTML 0001144204-11-055786.pdf 0001144204-11-055786.rtf 0001144204-11-055786.xls
Sep 30, 2011	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0001144204-11-055788.pdf 0001144204-11-055788.rtf 0001144204-11-055788.xls
Sep 30, 2011	EFFECT	EFFECT	View HTML 9999999995-11-002842.pdf 9999999995-11-002842.rtf 9999999995-11-002842.xls
Sep 19, 2011	4	Statement of changes in beneficial ownership of securities	View HTML 0001144204-11-053728.pdf 0001144204-11-053728.rtf 0001144204-11-053728.xls
Sep 16, 2011	8-K	Report of unscheduled material events or corporate event	View HTML 0001144204-11-053568.pdf 0001144204-11-053568.rtf 0001144204-11-053568.xls
Sep 16, 2011	S-3/A	Pre-effective amendment to an S-3 filing	View HTML 0001144204-11-053583.pdf 0001144204-11-053583.rtf 0001144204-11-053583.xls